Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             113 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accommodation in abo-incompatible kidney transplantation: why do kidney grafts survive? Takahashi, K
 2004
 36 2S p. S193-S196
4 p.
 artikel
2 Application of cyclosporine in renal transplantation: experience at the university of padua Furian, L
 2004
 36 2S p. S148-S151
4 p.
 artikel
3 A prospective trial of steroid withdrawal after renal transplantation in children: results obtained 1990 and 2002 Hasegawa, A
 2004
 36 2S p. S216-S219
4 p.
 artikel
4 Author index 2004
 36 2S p. S581-S583
3 p.
 artikel
5 Cardiac transplant experience with cyclosporine Patel, J.K
 2004
 36 2S p. S323-S330
8 p.
 artikel
6 Clinical success of NEORAL absorption profile Uchida, K
 2004
 36 2S p. S461-S464
4 p.
 artikel
7 Composite outcomes in renal transplantation using cyclosporine Keown, P.A
 2004
 36 2S p. S35-S39
5 p.
 artikel
8 Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant patients: preliminary results from the Myfortic Prospective Multicenter Study Nashan, B
 2004
 36 2S p. S521-S523
3 p.
 artikel
9 Conversion from tacrolimus to cyclosporine microemulsion therapy in liver transplant recipients Ogino, S
 2004
 36 2S p. S299-S301
3 p.
 artikel
10 Correlation between neoral 2 hours post-dose levels and histologic findings on surveillance biopsies Barama, A
 2004
 36 2S p. S465-S467
3 p.
 artikel
11 Cyclosporine-a-based immunosuppression and renal functional reserve in organ-transplant patients Kamar, N.
 2004
 36 2S p. S248-S250
3 p.
 artikel
12 Cyclosporine: advantages versus disadvantages vis-à-vis tacrolimus Maes, B.D
 2004
 36 2S p. S40-S49
10 p.
 artikel
13 Cyclosporine as a milestone in immunosuppression Calne, R
 2004
 36 2S p. S13-S15
3 p.
 artikel
14 Cyclosporine-Induced renal dysfunction Paul, L.C
 2004
 36 2S p. S224-S228
5 p.
 artikel
15 Cyclosporine in pediatric kidney transplantation Pape, L
 2004
 36 2S p. S203-S207
5 p.
 artikel
16 Cyclosporine in renal transplantation: a scottish experience Jardine, A.G
 2004
 36 2S p. S139-S142
4 p.
 artikel
17 Cyclosporine in thoracic organ transplantation Banner, N.R
 2004
 36 2S p. S302-S308
7 p.
 artikel
18 Cyclosporine—lessons from the first 20 years Cortesini, R.
 2004
 36 2S p. S158-S162
5 p.
 artikel
19 Cyclosporine nephrotoxicity Fellström, B
 2004
 36 2S p. S220-S223
4 p.
 artikel
20 Cyclosporine nephrotoxicity Busauschina, A
 2004
 36 2S p. S229-S233
5 p.
 artikel
21 Cyclosporine nephrotoxicity Grinyó, J.M.
 2004
 36 2S p. S240-S242
3 p.
 artikel
22 Cyclosporine nephrotoxicity: how does it affect renal allograft function and transplant morphology? Morozumi, K
 2004
 36 2S p. S251-S256
6 p.
 artikel
23 Cyclosporine renal dysfunction Vı́tko, Š
 2004
 36 2S p. S243-S247
5 p.
 artikel
24 Cyclosporine: 20 years of experience at the university of munich Graeb, C
 2004
 36 2S p. S125-S129
5 p.
 artikel
25 Early experience with cyclosporine: a historic perspective Kostakis, A
 2004
 36 2S p. S22-S24
3 p.
 artikel
26 Early steroid withdrawal protocol using basiliximab in kidney transplantation Teraoka, S
 2004
 36 2S p. S478-S482
5 p.
 artikel
27 Enteric-coated mycophenolate sodium: safe conversion from mycophenolate mofetil in maintenance renal transplant recipients Budde, K
 2004
 36 2S p. S524-S527
4 p.
 artikel
28 Enteric-coated mycophenolate sodium: therapeutic equivalence to mycophenolate mofetil in de novo renal transplant patients Sollinger, H
 2004
 36 2S p. S517-S520
4 p.
 artikel
29 Evolution of immunosuppression at the University of Minnesota Matas, A.J
 2004
 36 2S p. S64-S70
7 p.
 artikel
30 Evolution of immunosuppression in liver transplantation: contribution of cyclosporine Furukawa, H
 2004
 36 2S p. S274-S284
11 p.
 artikel
31 Evolution of the therapeutic drug monitoring of cyclosporine Citterio, F
 2004
 36 2S p. S420-S425
6 p.
 artikel
32 Experience with conversion from sandimmun to neoral cyclosporine and the correlation of c2 levels with renal function Konstadinidou, I
 2004
 36 2S p. S163-S166
4 p.
 artikel
33 Experience with cyclosporine Curtis, J.J.
 2004
 36 2S p. S54-S58
5 p.
 artikel
34 Experience with cyclosporine Langone, A.J.
 2004
 36 2S p. S59-S63
5 p.
 artikel
35 Experience with cyclosporine Ready, A.
 2004
 36 2S p. S135-S138
4 p.
 artikel
36 Experience with cyclosporine Sandrini, S
 2004
 36 2S p. S152-S157
6 p.
 artikel
37 Experience with cyclosporine Billing-Grima, M
 2004
 36 2S p. S285-S290
6 p.
 artikel
38 Experience with cyclosporine: approaching the therapeutic window for C 2 levels in maintenance kidney transplant recipients Di Paolo, S
 2004
 36 2S p. S434-S436
3 p.
 artikel
39 Experience with cyclosporine: from revolution to evolution of immunosuppressive protocols in thoracic organ transplantation Haverich, A
 2004
 36 2S p. S314-S317
4 p.
 artikel
40 Experience with cyclosporine in adult living donor kidney transplantation: from 1984 to 2002 at yonsei university Kim, S.I
 2004
 36 2S p. S186-S192
7 p.
 artikel
41 Experience with cyclosporine in endogenous uveitis posterior Hesselink, D.A
 2004
 36 2S p. S372-S377
6 p.
 artikel
42 Experience with cyclosporine in heart transplantation Sivathasan, C
 2004
 36 2S p. S346-S348
3 p.
 artikel
43 Experience with cyclosporine in 1519 kidney transplantations from living donors in a national transplant programme, 1983–2002 Albrechtsen, D
 2004
 36 2S p. S89-S93
5 p.
 artikel
44 Experience with cyclosporine in living-donor lobar lung transplantation Date, H
 2004
 36 2S p. S349-S351
3 p.
 artikel
45 Experience with cyclosporine in pediatric renal transplantation Willetts, I.E
 2004
 36 2S p. S211-S215
5 p.
 artikel
46 Experience with cyclosporine in the canary islands Hernández, D
 2004
 36 2S p. S120-S124
5 p.
 artikel
47 Experience with everolimus Augustine, J.J
 2004
 36 2S p. S500-S503
4 p.
 artikel
48 Experience with simulect Henry, M.L
 2004
 36 2S p. S471-S474
4 p.
 artikel
49 Experience with therapeutic drug monitoring of cyclosporine Abendroth, D
 2004
 36 2S p. S426-S429
4 p.
 artikel
50 Follow-up study of renal transplant recipients treated at the guatemalan social security hospital Sánchez-Polo, V
 2004
 36 2S p. S454-S455
2 p.
 artikel
51 From cyclosporine to the future Ponticelli, C
 2004
 36 2S p. S557-S560
4 p.
 artikel
52 FTY720: early clinical experience Dragun, D
 2004
 36 2S p. S544-S548
5 p.
 artikel
53 FTY720: from bench to bedside Kahan, B.D
 2004
 36 2S p. S531-S543
13 p.
 artikel
54 FTY720 immunomodulation: optimism for improved transplant regimens Ferguson, R
 2004
 36 2S p. S549-S553
5 p.
 artikel
55 Future directions in immunosuppression Beckebaum, S.
 2004
 36 2S p. S574-S576
3 p.
 artikel
56 History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion Cantarovich, M
 2004
 36 2S p. S442-S447
6 p.
 artikel
57 Immunosuppression for cardiac transplantation—the past, present and future O'Neill, J.O
 2004
 36 2S p. S309-S313
5 p.
 artikel
58 Immunosuppression for pancreatic islet transplantation Berney, T
 2004
 36 2S p. S362-S366
5 p.
 artikel
59 Immunosuppression in kidney transplantation in poland Pa̧czek, L.
 2004
 36 2S p. S173-S176
4 p.
 artikel
60 Impact of C2 measurement on cyclosporine neoral dosing in a Latin-American transplant program: the Guatemalan experience García-Gallont, R
 2004
 36 2S p. S451-S453
3 p.
 artikel
61 Impact of cyclosporine in the development of immunosuppressive therapy Chaverri, C.
 2004
 36 2S p. S80-S82
3 p.
 artikel
62 Impact of cyclosporine on cardiac transplantation in Berlin Hummel, M
 2004
 36 2S p. S337-S345
9 p.
 artikel
63 Impact of cyclosporine on the development of immunosuppressive therapy Fritsche, L
 2004
 36 2S p. S130-S134
5 p.
 artikel
64 Impact of cyclosporine on the development of immunosuppressive therapy in liver transplantation Taltavull, T.Casanovas
 2004
 36 2S p. S291-S294
4 p.
 artikel
65 Insights into subclinical rejection Rush, D
 2004
 36 2S p. S71-S73
3 p.
 artikel
66 Investigation of the pharmacokinetics of cyclosporine in patients following long-term administration after a kidney transplant: comparison of neoral and sandimmune Takahara, S
 2004
 36 2S p. S456-S460
5 p.
 artikel
67 Learning and new discovery with cyclosporine in the cambridge-king's programme: a personal view Williams, R.
 2004
 36 2S p. S261-S266
6 p.
 artikel
68 Lessons from cyclosporine monotherapy in renal transplantation: the impact of acute rejection on long-term allograft outcome Coll, E
 2004
 36 2S p. S114-S116
3 p.
 artikel
69 Living related liver transplantation Takada, Y
 2004
 36 2S p. S271-S273
3 p.
 artikel
70 Long-term kidney transplant outcomes in patients receiving oil-based or microemulsion formulations of cyclosporine Medina-Pestana, J.O
 2004
 36 2S p. S74-S79
6 p.
 artikel
71 Monitoring of T-cell subsets in patients treated with anti-CD 25 antibody Praditpornsilpa, K
 2004
 36 2S p. S487-S491
5 p.
 artikel
72 Neoral C2 monitoring in solid organ transplantation Levy, G.A
 2004
 36 2S p. S392-S395
4 p.
 artikel
73 Nephrotoxic aspects of cyclosporine Cattaneo, D
 2004
 36 2S p. S234-S239
6 p.
 artikel
74 New concepts in cyclosporine pharmacokinetic and dynamic monitoring: the impact of concomitant immunosuppression on target C2 concentrations Brunet, M
 2004
 36 2S p. S437-S441
5 p.
 artikel
75 Novartis celebrates 20 years in transplantation Rosenberg, Tony
 2004
 36 2S p. S9-S10
2 p.
 artikel
76 Optimization of cyclosporine for liver transplantation Lilly, L.B
 2004
 36 2S p. S267-S270
4 p.
 artikel
77 Optimization of the use of cyclosporine in renal transplantation Yoshimura, N
 2004
 36 2S p. S181-S185
5 p.
 artikel
78 Optimizing the use of cyclosporine (neoral) for recipients of living donor kidneys Vincenti, F
 2004
 36 2S p. S50-S53
4 p.
 artikel
79 Pancreas–Kidney transplantation in Japan: impact of cyclosporine on the development of immunosuppressive therapy Sugitani, A
 2004
 36 2S p. S356-S361
6 p.
 artikel
80 Pharmacologic monitoring and outcomes of cyclosporine Pollard, S.G
 2004
 36 2S p. S404-S407
4 p.
 artikel
81 Pharmacology of calcineurin antagonists Kapturczak, M.H
 2004
 36 2S p. S25-S32
8 p.
 artikel
82 Preservation of renal function during maintenance therapy with cyclosporine Serón, D
 2004
 36 2S p. S257-S260
4 p.
 artikel
83 Promise of neoral C2, basiliximab, and everolimus in lung transplantation Poirier, C.D
 2004
 36 2S p. S509-S513
5 p.
 artikel
84 Renal outcome of children exposed to cyclosporine in utero Cochat, P
 2004
 36 2S p. S208-S210
3 p.
 artikel
85 Role of hla molecules in the induction of alloimmune responses: clinical significance in the cyclosporine era Thorsby, E
 2004
 36 2S p. S16-S21
6 p.
 artikel
86 Simulect and HHV-6 in pediatric renal transplantation Acott, P.D
 2004
 36 2S p. S483-S486
4 p.
 artikel
87 Simulect induction facilitates neoral-based steroid-free immunosuppression in primary kidney transplant recipients Kung, S.-C
 2004
 36 2S p. S475-S477
3 p.
 artikel
88 Single-Center experience with cyclosporine therapy for kidney transplantation: analysis of a Twenty-Year period in 1200 patients Snanoudj, R
 2004
 36 2S p. S83-S88
6 p.
 artikel
89 Spanish experience with cyclosporine Pascual, J
 2004
 36 2S p. S117-S119
3 p.
 artikel
90 Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants Lucan, M
 2004
 36 2S p. S177-S180
4 p.
 artikel
91 The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? Izawa, A
 2004
 36 2S p. S570-S573
4 p.
 artikel
92 The era of cyclosporine: twenty years forward, Twenty years back 2004
 36 2S p. S5-S6
2 p.
 artikel
93 The evolving experience using everolimus in clinical transplantation Formica Jr, R.N
 2004
 36 2S p. S495-S499
5 p.
 artikel
94 The future of immunosuppression: a personal view Morris, R.E.
 2004
 36 2S p. S577-S579
3 p.
 artikel
95 The impact of cyclosporine on the development of immunosuppressive therapy Haberal, M
 2004
 36 2S p. S143-S147
5 p.
 artikel
96 The impact of cyclosporine on the development of immunosuppressive therapy for pediatric liver transplantation Burdelski, M.M
 2004
 36 2S p. S295-S298
4 p.
 artikel
97 The impact of cyclosporine on the development of immunosuppressive therapy—pediatric transplantation using cyclosporine Hoyer, P.F
 2004
 36 2S p. S197-S202
6 p.
 artikel
98 The impact of cyclosporine on the development of immunosuppressive therapy: perspective from a transplant nephrologist involved with the development of C2 Cole, E
 2004
 36 2S p. S408-S413
6 p.
 artikel
99 The promise of C2, simulect, and certican in heart transplantation Delgado, D.H
 2004
 36 2S p. S504-S508
5 p.
 artikel
100 Therapeutic drug monitoring of cyclosporine Jorga, A
 2004
 36 2S p. S396-S403
8 p.
 artikel
101 Therapeutic drug monitoring of cyclosporine Midtvedt, K
 2004
 36 2S p. S430-S433
4 p.
 artikel
102 Therapeutic drug monitoring of cyclosporine: 20 years of progress Kahan, B.D
 2004
 36 2S p. S378-S391
14 p.
 artikel
103 Therapeutic monitoring of cyclosporine in kidney transplantation: the Halifax experience Singh, D
 2004
 36 2S p. S414-S419
6 p.
 artikel
104 The use of cyclosporine in renal and pancreas transplantation Squifflet, J.-P
 2004
 36 2S p. S352-S355
4 p.
 artikel
105 The use of cyclosporine in renal transplantation Hesselink, D.A
 2004
 36 2S p. S99-S106
8 p.
 artikel
106 Tolerance mechanisms and recent progress Chan, C
 2004
 36 2S p. S561-S569
9 p.
 artikel
107 Total cholesterol correlates with cyclosporine C2 levels in kidney transplant recipients under maintenance immunosuppression Cardinal, H
 2004
 36 2S p. S448-S450
3 p.
 artikel
108 Two decades of experience with cyclosporine in renal transplantation in helsinki Salmela, K.T
 2004
 36 2S p. S94-S98
5 p.
 artikel
109 Use of cyclosporine in hematopoietic cell transplantation Hogan, W.J
 2004
 36 2S p. S367-S371
5 p.
 artikel
110 Use of cyclosporine in lung transplantation Parekh, K
 2004
 36 2S p. S318-S322
5 p.
 artikel
111 Use of cyclosporine in renal transplantation Kyriakides, G
 2004
 36 2S p. S167-S172
6 p.
 artikel
112 Use of cyclosporine in renal transplantation Lloveras, J
 2004
 36 2S p. S107-S113
7 p.
 artikel
113 Use of cyclosporine in thoracic transplantation Zuckermann, A
 2004
 36 2S p. S331-S336
6 p.
 artikel
                             113 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland